Can a Redness-Relief drop help glaucoma eyes without side effects?
NCT ID NCT04007276
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether Lumify, a low-dose brimonidine eye drop already approved for redness, can safely reduce eye redness and eyelid droop in 60 glaucoma patients who already use stronger brimonidine drops. Researchers will measure redness, eye pressure, and eyelid position after a single dose. The goal is to see if this lower concentration can relieve a common side effect without harming glaucoma control.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
brimonidine tartrate ophthalmic solution 0.025% (Lumify)
What this could lead to
If it works, this could offer glaucoma patients a way to reduce eye redness without raising eye pressure or causing droopy eyelids.
What could go wrong
This is a small, early-phase trial with only 60 participants. The lower dose may not work as well as expected, and individual results may vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tulane University Medical Center
New Orleans, Louisiana, 70112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact